Last mentioned: Mar 21, 2026
Public Disclosure
Mike Fincke details the medical issue that led to his early return from the ISS.
NASA Medical Review
Internal review of mission data to assess physiological impacts on crew rotation.
Early Return
Fincke departs the ISS ahead of schedule citing health concerns.
Mission Launch
Fincke arrives at the ISS for his scheduled long-duration mission.
As the International Space Station nears its scheduled 2030 retirement, NASA faces a critical timeline to transition to commercial successors. A failure to launch private stations before the ISS deorbits could cede low-Earth orbit dominance to China and halt decades of critical microgravity research.
NASA astronaut Mike Fincke has publicly detailed a medical condition that led to the premature conclusion of his recent mission to the International Space Station. This rare disclosure highlights the physiological challenges of long-duration orbital flight and the stringent health protocols governing the U.S. space program.